South Africa launches plan to curb rampant TB in gold mines

March 24, 2012

South Africa on Saturday launched a plan to diagnose tuberculosis in the country's gold mines, where the disease's incidence is the highest in the world.

Speaking to mine managers in Driefontein, Deputy President Kgalema Motlanthe said the goal was to "ensure that all mine workers, particularly in the gold mining sector, are screened and tested for TB and HIV over the next 12 months."

The Driefontein Fields gold mine, located about 70 kilometres (40 miles) north of Johannesburg, is a flagship for an industry that has been on the decline but remains lucrative and employs more than 160,000 people.

is rampant in all South African mines but incidence is particular high in due to horrendous conditions causing illnesses such as silicosis, which destroys the lungs of exposed to silica dust.

Gold mines are often older than platinum mines for example and workers at Driefontein sometimes descend as deep as 12,000 feet below the surface to hoist back tonnes of rock.

"Most of us may not be aware that gold mines have three times the amount of TB compared to the general population," Motlanthe said.

The campaign aims to equip the mines' health teams with a new diagnosis system, GeneXpert.

Motlanthe said the latest screening campaign showed that seven percent of those tested positive were found to have drug-resistant tuberculosis.

Related Stories

Recommended for you

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.